Download PDF
Synthesis 2005(9): 1397-1404  
DOI: 10.1055/s-2005-865308
PAPER
© Georg Thieme Verlag Stuttgart · New York

Regioselective Addition of n-Alkyllithiums to α,α′-Disubstituted-1,8-Naphthyridines: Synthesis of 6-Amino-3-Pyridinol Analogs of α-Tocopherol

Tae-gyu Nama, Maikel Wijtmansa,, Derek A. Pratt*b,, Ned A. Porter*a
a Department of Chemistry, Vanderbilt University, Nashville, Tennessee 37235, USA
b Department of Chemistry, University of Illinois at Urbana-Champaign, Urbana, Illinois 61801, USA
e-Mail: dpratt@uiuc.edu; e-Mail: n.porter@vanderbilt.edu;
Further Information

Publication History

Received 15 February 2005
Publication Date:
18 April 2005 (online)

    Permissions and Reprints All articles of this category

Abstract

n-Alkyllithiums were added to α,α′-disubstituted-1,8-naphthyridines in non-polar solvents such as Et2O-hexane mixtures. In polar solvents such as THF, alkyllithium acts as a base rather than a nucleophile. Regioselective addition was achieved for substrates capable of five-membered cyclic chelation of the (alkyl)lithium reagent. Substrates with a TBS-protected alcohol as the co-chelating moiety afforded the best combination of yield and regioselectivity. This methodology was successfully employed in the preparation of two 6-amino-3-pyridinol analogs of pentamethylchromanol (PMC), an α-tocopherol derivative with its isoprenoid side chain truncated to a methyl group.

Key words

1,8-naphthyridine - alkyllithium - chelation - solvent effects - α-tocopherol

    References

  • 3a Badawneh M. Manera C. Mori C. Saccomanni G. Ferrarini PL. Farmaco  2002,  57:  631 
    Google Scholar
  • 3b Leonard JT. Gangadhar R. Gnanasam SK. Ramachandran S. Saravanan M. Sridhar SK. Biol. Pharm. Bull.  2002,  25:  798 
    Google Scholar
  • 3c Misbahi H. Brouant P. Hever A. Molnar AM. Wolfard K. Spengler G. Mefetah H. Molnar J. Barbe J. Anticancer Res.  2002,  22:  2097 
    Google Scholar
  • 4a Tomon T. Ooyama D. Wada T. Shiren K. Tanaka K. Chem. Commun.  2001,  1100 
    CrossrefGoogle Scholar
  • 4b He C. DuBois JL. Hedman B. Hodgson KO. Lippard SJ. Angew. Chem. Int. Ed.  2001,  40:  1484 
    CrossrefGoogle Scholar
  • 4c He C. Lippard SJ. Tetrahedron  2000,  56:  8245 
    CrossrefGoogle Scholar
  • 5a Ferrarini PL. Mori C. Badawneh M. Calderone V. Greco R. Manera C. Martinelli A. Nieri P. Saccomanni G. Eur. J. Med. Chem.  2000,  35:  815 
    CrossrefGoogle Scholar
  • 5b Saccomanni G. Badawneh M. Adinolfi B. Calderone V. Cavallini T. Ferrarini PL. Greco R. Manera C. Testai L. Bioorg. Med. Chem.  2003,  11:  4921 
    CrossrefGoogle Scholar
  • 6a Duggan M. E., Duong L. T., Fisher J. E., Hamill T. G., Hoffman W. F., Huff J. R., Ihle N. C., Leu C. T., Nagy R. M., Perkins J. J., Rodan S. B., Wesolowski G., Whitman D. B., Zartman A. E., Rodan G. A., Hartman G. D.; J. Med. Chem.; 2000, 43: 3736
  • 6b Meissner R. S., Perkins J. J., Duong L. T., Hartman G. D., Hoffman W. F., Huff J. R., Ihle N. C., Leu C. T., Nagy R. M., Naylor-Olsen A., Rodan G. A., Rodan S. B., Whitman D. B., Wesolowski G. A., Duggan M. E.; Bioorg. Med. Chem. Lett.; 2002, 12: 25
  • 7a Wijtmans M. Pratt DA. Valgimigli L. DiLabio GA. Pedulli GF. Porter NA. Angew. Chem. Int. Ed.  2003,  42:  4370 
    CrossrefGoogle Scholar
  • 7b Wijtmans M. Pratt DA. Brinkhorst J. Swerza R. Valgimigli L. Pedulli GF. Porter NA. J. Org. Chem.  2004,  69:  9215 
    CrossrefGoogle Scholar
  • 8 Burton GW. Ingold KU. J. Am. Chem. Soc.  1981,  103:  6472 
    CrossrefGoogle Scholar
  • 9a Traber MG. Ramakrishnan R. Kayden HJ. Proc. Natl. Acad. Sci., U.S.A.  1994,  91:  10005 
    CrossrefGoogle Scholar
  • 9b Traber MG. Free Radical Biol. Med.  1994,  16:  229 
    CrossrefGoogle Scholar
  • 10 Hamada Y. Takeuchi I. Sato M. Yakugaku Zasshi  1974,  94:  1328 
    Google Scholar
  • 11 Newkome GR. Theriot KJ. Majestic VK. Spruell PA. Baker GR. J. Org. Chem.  1990,  55:  2838 ; and references therein
    CrossrefGoogle Scholar
  • 12 Dietrichbuchecker CO. Marnot PA. Sauvage JP. Tetrahedron. Lett.  1982,  23:  5291 
    CrossrefGoogle Scholar
  • 13 Bhattacharjee D. Popp FD. J. Heterocycl. Chem.  1980,  17:  1211 
    CrossrefGoogle Scholar
  • 14 Evans DA. Cee VJ. Smith TE. Santiago KJ. Org. Lett.  1999,  1:  87 
    CrossrefGoogle Scholar
  • 15 Mansour TS. Wong TC. Kaiser EM. J. Chem. Soc., Perkin Trans. 2  1985,  2045 
    CrossrefGoogle Scholar
  • 16 Fuji K. Nakano S. Fujita E. Synthesis  1975,  276 
    Article in Thieme ConnectGoogle Scholar
  • 17 We speculate that a cyclopropane intermediate is formed by radical cyclization upon treatment of the initial Markovnikov adduct with NaBH4. Then, the cyclopropane ring opens in such a way that anti-Markovnikov alcohol is produced. Similar cyclopropane intermediates have been proposed in a conjugated diene system: Brown HC. Geoghegan PJ. Lynch GJ. Kurek JT. J. Org. Chem.  1972,  37:  1941 
    CrossrefGoogle Scholar
1

Current address: Department of Pharmacochemistry, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.

2

Current address: Department of Chemistry, Queen’s University, Kingston, Ontario, Canada.

18

Deprotection of TBS group in 16 resulted in unidentified by-product up to 50%.